Since the business may be at an important milestone, we thought we should take a closer look at agilon health, inc. of (NYSE: AGL) prospect. Agilon Health provides health care services to seniors through primary care physicians in communities across the United States. The $8.5b company lost $405 million in its most recent fiscal year and posted a trailing 12-month loss of $108 million, narrowing the gap between losses and breakeven. Many investors want to know how quickly Agilon Health will be profitable, and the big question is “When will the company break even?” Below we provide a high-level summary of industry analysts’ expectations for the company.
Check out our latest analysis for Agilon’s health
According to 15 industry analysts covering Agilent Health, the consensus is that breakeven is near. They expect the company to post an eventual loss in 2022 before turning around to a profit of $2.7 million in 2023. As a result, the company is on track to break even in about a year or less! We calculated how fast the company would have to grow to meet the consensus forecast forecasting breakeven within 12 months. As it turns out, the projected average annual growth rate of 57% shows that analysts are confident. If the business grows more slowly, it will be profitable later than expected.
The underlying developments driving Agilon Health’s growth are not the focus of this broad overview, but keep in mind that in general high growth rates are not uncommon, especially when a company is in an investment phase.
One thing we would like to point out is that the company manages its capital wisely, with debt at 4.1% of equity. This means it funds its operations primarily through equity capital, and its low debt obligations reduce the risk of investing in loss-making companies.
There are too many facets of agilon health to cover in a short article, but the key fundamentals of the company can all be found in one place – agilon health company page on Simply Wall St. We also have a list of related aspects you should check out:
- Valuation: How much is Agilon Health worth today? Is future growth potential priced in?This The intrinsic value infographic in our free research report helps visualize whether Agilon Health is currently mispriced by the market.
- management team: Experienced management team at the helm increases our confidence in the business – see Who sits on the board and CEO of Agilon Health in the background.
- Other outperforming stocks: Are there other stocks that offer better prospects and a solid track record?explore our A free list of these great stocks is here.
Valuation is complicated, but we’re helping make it simple.
find out if Jet Dragon Health It may be overvalued or undervalued by viewing our comprehensive analysis, which includes Fair value estimates, risks and caveats, dividends, insider trading and financial health.
View free analysis
Have feedback on this article? Concerned about content? keep in touch Contact us directly. Alternatively, email the editorial team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We use only an unbiased methodology to provide reviews based on historical data and analyst forecasts, and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock and does not take into account your objectives or your financial situation. Our goal is to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not take into account the latest price-sensitive company announcements or qualitative material. Simply Wall St has no positions in any of the stocks mentioned.